57 related articles for article (PubMed ID: 10027908)
1. Demonstration of the predominant urine osteocalcin fragments detectable by two-site immunoassays.
Matikainen T; Käkönen SM; Pettersson K; Karp M; Lövgren T; Väänänen Hk; Hellman J
J Bone Miner Res; 1999 Mar; 14(3):431-8. PubMed ID: 10027908
[TBL] [Abstract][Full Text] [Related]
2. Characterization of aged osteocalcin fragments derived from bone resorption.
Cloos PA; Christgau S
Clin Lab; 2004; 50(9-10):585-98. PubMed ID: 15481635
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping of nine monoclonal antibodies against osteocalcin: combinations into two-site assays affect both assay specificity and sample stability.
Hellman J; Käkönen SM; Matikainen MT; Karp M; Lövgren T; Väänänen HK; Pettersson K
J Bone Miner Res; 1996 Aug; 11(8):1165-75. PubMed ID: 8854253
[TBL] [Abstract][Full Text] [Related]
4. A urine midmolecule osteocalcin assay shows higher discriminatory power than a serum midmolecule osteocalcin assay during short-term alendronate treatment of osteoporotic patients.
Srivastava AK; Mohan S; Singer FR; Baylink DJ
Bone; 2002 Jul; 31(1):62-9. PubMed ID: 12110414
[TBL] [Abstract][Full Text] [Related]
5. A dual-label immunofluorometric assay for human osteocalcin.
Ylikoski A; Hellman J; Matikainen T; Käkönen SM; Karp M; Väänänen HK; Lövgren T; Pettersson K
J Bone Miner Res; 1998 Jul; 13(7):1183-90. PubMed ID: 9661083
[TBL] [Abstract][Full Text] [Related]
6. Multiple osteocalcin fragments in human urine and serum as detected by a midmolecule osteocalcin radioimmunoassay.
Taylor AK; Linkhart S; Mohan S; Christenson RA; Singer FR; Baylink DJ
J Clin Endocrinol Metab; 1990 Feb; 70(2):467-72. PubMed ID: 2298858
[TBL] [Abstract][Full Text] [Related]
7. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
[TBL] [Abstract][Full Text] [Related]
8. Fracture-induced changes in bone turnover: a potential confounder in the use of biochemical markers in osteoporosis.
Akesson K; Käkönen SM; Josefsson PO; Karlsson MK; Obrant KJ; Pettersson K
J Bone Miner Metab; 2005; 23(1):30-5. PubMed ID: 15616891
[TBL] [Abstract][Full Text] [Related]
9. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
[TBL] [Abstract][Full Text] [Related]
10. Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential.
Cloos PA; Fledelius C
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):473-80. PubMed ID: 10642504
[TBL] [Abstract][Full Text] [Related]
11. Effect of calcium fortified milk supplementation with or without vitamin K on biochemical markers of bone turnover in premenopausal women.
Kruger MC; Booth CL; Coad J; Schollum LM; Kuhn-Sherlock B; Shearer MJ
Nutrition; 2006; 22(11-12):1120-8. PubMed ID: 17030114
[TBL] [Abstract][Full Text] [Related]
12. The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjects.
Obrant KJ; Käkönen SM; Astermark J; Lilja H; Lövgren T; Akesson K; Pettersson K
J Bone Miner Res; 1999 Apr; 14(4):555-60. PubMed ID: 10234576
[TBL] [Abstract][Full Text] [Related]
13. Chemiluminescence immunometric assay for measuring osteocalcin in healthy children.
Fricke O; Stabrey A; Schönau E
Clin Lab; 2000; 46(5-6):281-4. PubMed ID: 10853237
[TBL] [Abstract][Full Text] [Related]
14. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
[TBL] [Abstract][Full Text] [Related]
15. A cross-sectional study of bone turnover markers in healthy premenopausal women.
de Papp AE; Bone HG; Caulfield MP; Kagan R; Buinewicz A; Chen E; Rosenberg E; Reitz RE
Bone; 2007 May; 40(5):1222-30. PubMed ID: 17331821
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the cDNA encoding bullfrog, Rana catesbeiana, osteocalcin and two forms of the protein isolated from bone.
Dohi Y; Tabata S; Yamaguchi M; Ohgushi H; Yonemasu K
Biochimie; 2004 Jul; 86(7):471-80. PubMed ID: 15308336
[TBL] [Abstract][Full Text] [Related]
17. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
18. Differential bone metabolism between postmenopausal women with osteoarthritis and osteoporosis.
Jiang LS; Zhang ZM; Jiang SD; Chen WH; Dai LY
J Bone Miner Res; 2008 Apr; 23(4):475-83. PubMed ID: 18052758
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.
Murphy MG; Bach MA; Plotkin D; Bolognese J; Ng J; Krupa D; Cerchio K; Gertz BJ
J Bone Miner Res; 1999 Jul; 14(7):1182-8. PubMed ID: 10404019
[TBL] [Abstract][Full Text] [Related]
20. Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study.
Garnero P; Mulleman D; Munoz F; Sornay-Rendu E; Delmas PD
J Bone Miner Res; 2003 Oct; 18(10):1789-94. PubMed ID: 14584889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
